Co-Occurring Alterations of ERBB2 Exon 20 Insertion in Non-Small Cell Lung Cancer (NSCLC) and the Potential Indicator of Response to Afatinib.
Yuan B, Zhao J, Zhou C, Wang X, Zhu B, Zhuo M, Dong X, Feng J, Yi C, Yang Y, Zhang H, Zhou W, Chen Z, Yang S, Ai X, Chen K, Cui X, Liu D, Shi C, Wu W, Zhang Y, Chang L, Li J, Chen R, Yang S.
Yuan B, et al. Among authors: wu w.
Front Oncol. 2020 May 12;10:729. doi: 10.3389/fonc.2020.00729. eCollection 2020.
Front Oncol. 2020.
PMID: 32477948
Free PMC article.